<DOC>
	<DOCNO>NCT02369926</DOCNO>
	<brief_summary>This study aim calibrate Multiple Sclerosis Functional Composite ( MSFC ) home implementation phase 2 trial lisinopril multiple sclerosis . In initial stage , participant require travel study site one day week three week complete MSFC . They also require complete MSFC home weekly three week use remote sense technology video conferencing .</brief_summary>
	<brief_title>Endpoint Calibration Phase 2 Study Lisinopril Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>1 . Males female age 18 64 . 2 . Documented informed consent 3 . Documented diagnosis RRMS via 2010 McDonald Criteria 4 . Normal blood pressure baseline : 90140 mmHg systolic AND 6090 mmHg diastolic 5 . Baseline score 05.5 Kurtzke 's Expanded Disability Status Scale ( EDSS ) 6 . Availability person home physically able willing steady subject s/he lose balance walk test . 1 . Hypotensive baseline : &lt; 90 mmHg systolic &lt; 60 mmHg diastolic 2 . Hypertensive baseline : &gt; 140 mmHg systolic &gt; 90 mmHg diastolic 3 . Bradycardia baseline : &lt; 50 bpm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>multiple sclerosis</keyword>
	<keyword>telemedicine</keyword>
	<keyword>remote monitoring</keyword>
	<keyword>lisinopril</keyword>
</DOC>